Učitavanje...
Use of Recombinant Factor VIIa in Patients With Warfarin-Associated Intracranial Hemorrhage
INTRODUCTION: Warfarin-associated intracranial hemorrhage (ICH) requires rapid normalization of clotting function. Current therapies are associated with significant complications and/or prolonged time to correction of coagulopathy. Recombinant factor VIIa (FVIIa) might allow faster and safer correct...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2005
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2535929/ https://ncbi.nlm.nih.gov/pubmed/16159073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1385/NCC:2:3:263 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|